| Requip-Modutab 8mg Prolonged-Release Tablets PPA0465/279/001 |
Ropinirole hydrochloride |
PCO Manufacturing Ltd. |
— |
| Resolor 1 mg film-coated tablets EU/1/09/581/001 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Resolor 2 mg film-coated tablets EU/1/09/581/002 |
Prucalopride Succinate |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Respreeza 1,000 mg powder and solvent for solution for infusion. EU/1/15/1006/001 |
Human alpha1-proteinase inhibitor |
CSL Behring GmbH |
— |
| Retacrit EU/1/07/431/17-19 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit EU/1/07/431/7-16 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retacrit 1000 IU/0.3 ml Solution for injection EU/1/07/431/1-6 |
Epoetin zeta |
Pfizer Europe MA EEIG |
— |
| Retrovir 10 mg/ml IV concentrate for solution for infusion PA22575/001/003 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Retrovir 100 mg capsules, hard PA22575/001/001 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Retrovir 100 mg/10 ml oral solution PA22575/001/002 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Retsevmo 120 mg film-coated tablets EU/1/20/1527/018-020 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 160 mg film-coated tablets EU/1/20/1527/021-023 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 40 mg film-coated tablets EU/1/20/1527/012-014 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 40 mg hard capsules EU/1/20/1527/001 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 80 mg film-coated tablets EU/1/20/1527/015-017 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Retsevmo 80 mg hard capsules EU/1/20/1527/002-003 |
Selpercatinib |
Eli Lilly Nederland B.V. |
— |
| Revatio 0.8 mg/ml solution for injection EU/1/05/318/002 |
Sildenafil citrate for parenteral use |
Upjohn EESV |
— |
| Revatio 10 mg/ml powder for oral suspension EU/1/05/318/003 |
Sildenafil citrate |
Upjohn EESV |
— |
| Revatio 20 mg film-coated tablets EU/1/05/318/001 |
Sildenafil |
Upjohn EESV |
— |
| REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) PA23458/005/001 |
Diphtheria toxoid, Tetanus toxoid, POLIOVIRUS, TYPE 1, Poliovirus, type 2, Poliovirus, type 3 |
Sanofi Winthrop Industrie |
Marketed |
| Revestive 1.25 mg powder and solvent for solution for injection EU/1/12/787/003 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revestive 5 mg powder and solvent for solution for injection EU/1/12/787/001 |
Teduglutide |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/929/004-006 |
Fluticasone furoate, Vilanterol |
GlaxoSmithKline (Ireland) Limited |
— |
| Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/929/001-003 |
Fluticasone furoate, Vilanterol |
GlaxoSmithKline (Ireland) Limited |
— |
| Revlimid 10 mg hard capsules EU/1/07/391/002 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 15 mg hard capsules EU/1/07/391/003 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 2.5 mg hard capsules EU/1/07/391/005 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 20 mg hard capsules EU/1/07/391/009 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 25 mg hard capsules EU/1/07/391/004 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 5 mg hard capsules EU/1/07/391/001 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revlimid 7.5 mg hard capsules EU/1/07/391/006 |
Lenalidomide |
Bristol-Myers Squibb Pharma EEIG |
— |
| Revolade 12.5 mg film-coated tablets EU/1/10/612/010-012 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 25 mg film-coated tablets EU/1/10/612/1-3 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 25 mg powder for oral suspension EU/1/10/612/013 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 50 mg film-coated tablets EU/1/10/612/4-6 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 75 mg film-coated tablets EU/1/10/612/007-009 |
Eltrombopag (sb-497115) |
Novartis Europharm Limited |
— |
| Reyataz EU/1/03/267/01-7 |
Atazanavir |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 300 mg hard capsules EU/1/03/267/8-9 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reyataz 50 mg oral powder EU/1/03/267/012 |
Atazanavir sulfate |
Bristol-Myers Squibb Pharma EEIG |
— |
| Rezdiffra 100 mg film-coated tablets EU/1/25/1962/003 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| Rezdiffra 60 mg film-coated tablets EU/1/25/1962/001 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| Rezdiffra 80 mg film-coated tablets EU/1/25/1962/002 |
Resmetirom |
Madrigal Pharmaceuticals EU Limited |
— |
| REZOLSTA 675 mg/150 mg film-coated tablets EU/1/14/967/002 |
Darunavir ethanolate, Cobicistat |
Janssen-Cilag International NV |
— |
| REZOLSTA 800 mg/150 mg film-coated tablets EU/1/14/967/001 |
Darunavir, Cobicistat |
Janssen-Cilag International NV |
— |
| REZZAYO 200 mg powder for concentrate for solution for infusion EU/1/23/1775/001 |
Rezafungin acetate |
Mundipharma GmbH |
— |
| Rhinex Relief 50 micrograms/actuation Nasal spray, suspension PA0711/279/001 |
Mometasone furoate |
Rowex Limited, |
Marketed |
| Rhinolast 140 micrograms per Spray, Nasal Spray PA25506/006/001 |
Azelastine hydrochloride |
Cooper Consumer Health B.V. |
Marketed |
| Rhinolast Hayfever 140 micrograms per spray, nasal spray solution PA25506/006/002 |
Azelastine hydrochloride |
Cooper Consumer Health B.V. |
Not marketed |
| Rhinolast S nasal spray, solution PA25506/006/003 |
Azelastine hydrochloride |
Cooper Consumer Health B.V. |
Not marketed |
| Rhokiinsa 200 micrograms/ml eye drops, solution EU/1/19/1400/001 |
NETARSUDIL MESILATE |
Santen OY |
— |